Search company, investor...

Integrated Biosystems

Founded Year



Series B - II | Alive

Total Raised


Last Raised

$16.23M | 22 yrs ago

About Integrated Biosystems

Integrated Biosystems (Napa, CA) is the world's leading supplier of controlled freeze and thaw technologies for storage and transport of specialized biopharmaceuticals. Integrated Biosystems, Inc. was acquired by Stedim S.A. (Euronext Paris: DIM).

Headquarters Location

445 Devlin Road

Napa, California, 94558,

United States


Missing: Integrated Biosystems's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: Integrated Biosystems's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

Integrated Biosystems Frequently Asked Questions (FAQ)

  • When was Integrated Biosystems founded?

    Integrated Biosystems was founded in 2002.

  • Where is Integrated Biosystems's headquarters?

    Integrated Biosystems's headquarters is located at 445 Devlin Road, Napa.

  • What is Integrated Biosystems's latest funding round?

    Integrated Biosystems's latest funding round is Series B - II.

  • How much did Integrated Biosystems raise?

    Integrated Biosystems raised a total of $31.73M.

  • Who are the investors of Integrated Biosystems?

    Investors of Integrated Biosystems include Asset Management Ventures, Sears Capital Management, Alloy Ventures and Montreux Equity Partners.

  • Who are Integrated Biosystems's competitors?

    Competitors of Integrated Biosystems include LungLife AI, Philogen, NGM Biopharmaceuticals, Integrated DNA Technologies, Althea Technologies and 12 more.

Compare Integrated Biosystems to Competitors

ASD Biosystems

ASD BioSystems, Inc. is working to be the market leader in providing total, integrated, ultra-portable, rugged, decontaminable, rapid systems for sample collection, tracking, analysis, reporting and management for a rapidly expanding biosafety market. The biosafety market includes biotechnology and manufacturing control testing, agricultural and veterinary testing, environmental testing, and responding to known or suspected acts of biological warfare, bioterrorism or other related criminal activity.

Blaze Systems Logo
Blaze Systems

Blaze Systems is a provider of total LIMS software solutions for the laboratory marketplace.


Viridaxis is a biotechnology firm working for integrated pest management.

Athena Environmental Sciences

AthenaES specializes in the development and commercialization of advanced biotechnology-based products. Throughout its eleven year history, the company has maintained a broad perspective for applying its core competency, the use of proteins and enzymes for commercial applications, to develop products. As such, the company currently markets its products and services through two business units and maintains an exploratory R&D group. The Athena Enzyme Systems Group aims to provide specialty reagents and proteins for the production and recovery of recombinant proteins along with providing contract R&D services. Products include: Expression Media, Serum-free Media, Protein Refolding kits, and the PDQ Protease Assay. This business unit also aims to provide specialized contract research, development and manufacturing services for the production of recombinant proteins. The Athena Environmental Services Group designs, develops and manufactures environmentally responsible products. Products developed include: The Bilge Pill, a biodegradable cleaning product for the removal of oil in boat bilges, and a plant nutrient supplement used in hydroponics, hobby gardens and horticulture that replaces conventional fertilizers, and the Sting Thing, an enzyme-based invertebrate sting treatment product. More recently, this group developed and has introduced a water-soluble, reversible glue, MagiGlue. The Athena Exploratory Science Group has the mission to pursue research with the potential for commercial, environmental and social impact. These projects are far reaching in their scope and represent high risk, high-value projects.


CombiSep Inc. has merged with Advanced Analytical Technologies, Inc. (AATI). aims to provide separation systems for the pharmaceutical, biotechnology, and chemical industries to increase productivity in discovery, development, and quality control processes. The cePRO 9600 system is a multiplexed capillary electrophoresis (CE) instrument providing near universal UV absorbance detection and the capability to perform 96 CE separations in parallel, increasing sample throughput. This technology aims to provide the company's customers with a key scientific and business advantage over traditional serial-based analytical methods, and aims to allow for quicker decisions on time-to-market strategies.


RevDia is a provider of a therapeutic diagnostic testing platform. The company's diagnostic testing platform is designed to detect an active periodontal infection. Its technology is intended to measure elevated levels of slgA in saliva that is specific to Aa and Pg virulence proteins, an attribute displayed by bacteria when it becomes pathogenic during an active infection.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.